Myriad Genetics MYGN Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's accumulated depreciation?
- Myriad Genetics (MYGN) reported accumulated depreciation of $90.5M in Q1 2026.
- How has Myriad Genetics's accumulated depreciation changed year-over-year?
- Myriad Genetics's accumulated depreciation increased by 8.4% year-over-year, from $83.5M to $90.5M.
- What is the long-term trend for Myriad Genetics's accumulated depreciation?
- Over 5 years (2020 to 2025), Myriad Genetics's accumulated depreciation has grown at a -4.9% compound annual growth rate (CAGR), from $112.9M to $87.9M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.